Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 1997

View Archived Issues

Trimidox enhances effects of doxorubicin in vivo

Preliminary clinical results for LMB-2

Update on Interferon Sciences' Alferon N Injection

LeukoSite and collaborators discover monoclonal antibody that blocks HIV infection

Osiris Therapeutics obtains U.S. patent for mesenchymal stem cell gene therapy

Titan receives U.S. patent for drug delivery to the CNS

Panax to acquire CorBec

FDA advisory committee votes against Myotrophin approval

Pfizer and Oncogene characterize EGF receptor TK inhibitor

Cubist and Novalon collaborative research agreement

Orally active FdUrd derivative prepared at Taiho

Prevention of breast cancer with Targretin

Menarini prepares new NNRTIs with potent anti-HIV activity

Preclinical characterization of aplidine

CRF receptor antagonist from Pfizer active in animal model of depression

Preclinical and preliminary clinical studies on flavopiridol

Oral toxicity of SarCNU in rats

Preliminary phase I results for dolastatin 10 in advanced solid tumors

Animal and human pharmacokinetics of 9-NC reported

Dura acquires two intranasal steroid products from Syntex

IL-18 evaluated for biological and antitumor activity

Data from U.K. phase III trial of Zacutex presented

RPR receives FDA clearance for new indication of enoxaparin

Forest submits NDA for antidepressant

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...